secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001140361-22-006505
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys appoints Dov Elefant as CFO effective Feb 28, 2022
----------------------------------------------------------

- Dov Elefant, former CFO of Cellectar Biosciences, named CFO of Femasys.
- Annual salary of $400,000; target bonus 40% of base salary.
- Inducement option for 100,000 shares, vesting over four years.
- Effective February 28, 2022, succeeding prior CFO arrangement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036122006505/0001140361-22-006505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036122006505/brhc10034387_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-006505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer